Pediatric Surgical Opioid Prescribing Concentrated Among a Few Procedures
By Elana Gotkine HealthDay Reporter
WEDNESDAY, June 26, 2024 -- Pediatric surgical opioid prescribing is concentrated among a small number of procedures, especially tonsillectomy and/or adenectomy, according to a study published online June 26 in Pediatrics.
Kao-Ping Chua, M.D., Ph.D., from the Institute for Healthcare Policy and Innovation in Ann Arbor, Michigan, and colleagues conducted a cross-sectional analysis of commercial and Medicaid claims to examine which surgical procedures account for the most pediatric surgical opioid prescribing. Surgical procedures performed among patients aged 0 to 21 years from Dec. 1, 2020, to Nov. 30, 2021, were included in the analyses. The total amount of opioids in prescriptions dispensed within three days of discharge from surgery was calculated, as measured in morphine milligram equivalents (MMEs).
The researchers found that the top three procedures accounted for 59.1 percent of MMEs in opioid prescriptions dispensed after surgery among 107,597 procedures for patients aged 0 to 11 years: tonsillectomy and/or adenoidectomy (50.3 percent), open treatment of upper extremity fracture (5.3 percent), and removal of deep implants (3.5 percent). The top three procedures accounted for 33.1 percent of MMEs among 111,406 procedures for patients aged 12 to 21 years: tonsillectomy and/or adenoidectomy (12.7 percent), knee arthroscopy (12.6 percent), and cesarean delivery (7.8 percent).
"Targeting these procedures in opioid stewardship initiatives could help minimize the risks of opioid prescribing while maintaining effective postoperative pain control," the authors write.
One author disclosed ties to the pharmaceutical industry and has provided expert medical testimony.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer
THURSDAY, June 5, 2025 -- For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel...
Youth Deaths Attributable to Synthetic Opioids Alone Increasingly Predominant
THURSDAY, May 29, 2025 -- Among U.S. youth, overdose deaths attributable to synthetic opioids alone are increasingly predominant, according to a study published online May 20 in...
Endolymphatic Sac Decompression Effective for Vertigo, Migraine
WEDNESDAY, May 28, 2025 -- For Meniere disease (MD) patients with migraine, endolymphatic sac decompression (ELSD) is effective, providing postoperative relief of vertigo and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.